Illumina Newswire

Illumina Newswire

Comprehensive Real-Time News Feed for Illumina.

Results 1 - 20 of 367 in Illumina

  1. Investment Analysts' Weekly Ratings Changes for IlluminaRead the original story

    6 min ago | AmericanBankingNews.com

    They set a "buy" rating and a $265.00 price target on the stock. 8/22/2015 - Illumina had its "buy" rating reaffirmed by analysts at Canaccord Genuity.

    Comment?

  2. Illumina Director Sells $390,160.00 in StockRead the original story

    23 hrs ago | AmericanBankingNews.com

    Illumina Director David R. Walt sold 2,000 shares of the company's stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $195.08, for a total value of $390,160.00.

    Comment?

  3. Illumina Completes Acquisition Of GenoLogics Life Sciences Software Inc.Read the original story

    Monday Aug 31 | BioSpace

    Illumina, Inc. today announced it has completed the acquisition of GenoLogics Life Science Software Inc., a developer of industry leading laboratory information management systems for life sciences organizations. "We look forward to working with the talented team at GenoLogics and to further integrate their life science software as part of the overall Illumina informatics solution," said Francis deSouza, President of Illumina.

    Comment?

  4. Illumina Completes GenoLogics AcquisitionRead the original story

    Tuesday | SocalTECH.com

    San Diego-based life sciences equipment maker Illumina said today that it has completed its acquisition of GeneLogics Life Sciences Software , which makes laboratory information management systems for the life sciences industry. Financial details of the deal have not been announced.

    Comment?

  5. Illumina Completes Acquisition of GenoLogicsRead the original story

    Tuesday | Freshnews

    Illumina, Inc. today announced it has completed the acquisition of GenoLogics Life Science Software Inc., a developer of industry leading laboratory information management systems for life sciences organizations. "We look forward to working with the talented team at GenoLogics and to further integrate their life science software as part of the overall Illumina informatics solution," said Francis deSouza, President of Illumina.

    Comment?

  6. Illumina (ILMN) Stock Initiated with a 'Buy' Rating at Cantor FitzgeraldRead the original story w/Photo

    Thursday Aug 27 | TheStreet.com

    The firm cited the company's leadership position in the genetic sequencing market as its reasoning for the "buy" rating. Illumina has an 80% share of the $2.3 billion market, which is expected to grow exponentially in the next 10 years, according to Cantor Fitzgerald.

    Comment?

  7. Illumina Research Coverage Started at Cantor FitzgeraldRead the original story

    Wednesday Aug 26 | AmericanBankingNews.com

    The brokerage set a "buy" rating on the life sciences company's stock. In other Illumina news, Director A Blaine Bowman sold 3,000 shares of the stock in a transaction that occurred on Wednesday, June 24th.

    Comment?

  8. Illumina Rating Increased to Focus List at Citigroup Inc.Read the original story

    Wednesday Aug 26 | AmericanBankingNews.com

    Several other equities research analysts have also recently issued reports on the company. Vetr lowered Illumina from a "hold" rating to a "sell" rating and set a $194.01 price target for the company.

    Comment?

  9. Research Analysts' Weekly Ratings Updates for IlluminaRead the original story

    Wednesday Aug 26 | AmericanBankingNews.com

    They now have a $250.00 price target on the stock. 8/20/2015 - Illumina was downgraded by analysts at Zacks from a "buy" rating to a "hold" rating.

    Comment?

  10. Burning Rock And Illumina Collaborate On Molecular Diagnostics For OncologyRead the original story

    Monday Aug 24 | BioSpace

    GUANGZHOU, China & SAN DIEGO-- --Burning Rock and Illumina, Inc. today announced they have entered into an agreement whereby Burning Rock will develop advanced clinical applications for molecular diagnostics in oncology based on Illumina's next-generation sequencing technology. The collaboration highlights the ever-increasing importance of genomics to improve healthcare in China.

    Comment?

  11. Burning Rock and Illumina Collaborate on Molecular Diagnostics for OncologyRead the original story

    Monday Aug 24 | Business Wire

    )--Burning Rock and Illumina, Inc. (NASDAQ: ILMN) today announced they have entered into an agreement whereby Burning Rock will develop advanced clinical applications for molecular diagnostics in oncology based on Illumina's next-generation ...

    Comment?

  12. A new $100 million company could transform the way we interact with our own DNARead the original story

    Monday Aug 24 | Silicon Alley Insider

    ... genome. A new company called Helix , launched August 18 with $100 million in investments by partners including Illumina - one of the world-leaders in genome-sequencing - wants to change all that. Helix wants to be the hub that connects people ...

    Comment?

  13. Mayo Clinic joins Illumina, Warburg Pincus, and Sutter Hill Ventures...Read the original story

    Monday Aug 24 | Holtville Tribune

    Illumina, Inc., Warburg Pincus and Sutter Hill Ventures announced Tuesday that they have formed a company to empower consumers to discover insights into their own genomes through a vibrant ecosystem of high-quality content partners. The company, called Helix, is based in the San Francisco Bay Area and received financing commitments in excess of $100 million.

    Comment?

  14. Canaccord Genuity Reaffirms "Buy" Rating for IlluminaRead the original story

    Saturday Aug 22 | AmericanBankingNews.com

    ... Canaccord Genuity's target price indicates a potential upside of 25.03% from the company's current price. Shares of Illumina ( NASDAQ:ILMN ) opened at 199.95 on Friday. The stock has a 50 day moving average price of $217.21 and a 200 day moving ...

    Comment?

  15. Illumina Rating Reiterated by MizuhoRead the original story

    Thursday Aug 20 | AmericanBankingNews.com

    ... of $240.00. Mizuho's price objective would suggest a potential upside of 24.73% from the stock's previous close. Illumina ( NASDAQ:ILMN ) traded down 2.54% during midday trading on Wednesday, hitting $200.43. 1,129,047 shares of the stock were ...

    Comment?

  16. How SD Beats SV for Tech StartupsRead the original story w/Photo

    Thursday Aug 20 | GlobeSt.com

    ... analytics offer new frontiers for tech entrepreneurs.' He adds that proximity to industry giants like Qualcomm, Illumina and Thermo Fisher Scientific offer entrepreneurs in this emerging tech space access to new communication and health technologies ...

    Comment?

  17. Zacks Downgrades Illumina to HoldRead the original story

    Thursday Aug 20 | AmericanBankingNews.com

    According to Zacks, "Illumina ended the second quarter of 2015 on a mixed note. The company's bottom line comfortably exceeded the Zacks Consensus Estimate, while the top line missed the same.

    Comment?

  18. The iShares Exponential Technology ETF Dilutes Exposure With Blue ChipsRead the original story w/Photo

    Thursday Aug 20 | Seeking Alpha

    ... in the underlying index. While the fund provides solid exposure to up-and-coming technology companies, such as Illumina (NASDAQ: ILMN ), Splunk (NASDAQ: SPLK ) and Hologic (NASDAQ: HOLX ), it also holds well-established blue chip companies like ...

    Comment?

  19. Market Has Been Irrational About Semiconductors - Cramer's Lightning RoundRead the original story w/Photo

    Thursday Aug 20 | Seeking Alpha

    ... ): "Tractor supply is constantly jammed and that is a niche retailer that I like very much. I say stick with it." Illumina (NASDAQ: ILMN ): "I see you with Illumina, and I raise you with Thermo Fisher Scientific (NYSE: TMO )." Cramer prefers the ...

    Comment?

  20. Illumina Earns Buy Rating from BTIG ResearchRead the original story

    Wednesday Aug 19 | AmericanBankingNews.com

    ... stock. BTIG Research's price target points to a potential upside of 16.70% from the stock's current price. In other Illumina news, Director A Blaine Bowman sold 3,000 shares of the company's stock in a transaction that occurred on Friday, May 22nd. ...

    Comment?